Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Preclinical Characterization of Anlotinib: Potent Angiogenes
2026-06-23
The reference study establishes anlotinib hydrochloride as a highly selective and potent inhibitor of VEGFR2, with significant anti-angiogenic activity in preclinical cancer models. These findings highlight anlotinib's promise as a multi-target tyrosine kinase inhibitor for advanced cancer research, particularly where endothelial cell migration and angiogenesis are central.
-
ABT-737: BCL-2 Protein Inhibitor for Apoptosis in Cancer Res
2026-06-23
ABT-737 delivers targeted apoptosis induction in cancer cells, enabling mechanistic and translational breakthroughs in oncology research. This guide covers optimized workflows, troubleshooting, and novel insights from recent senolytic studies to help researchers maximize the impact of ABT-737 in complex experimental settings.
-
ABT-737 (SKU A8193): Empowering Reliable Apoptosis Assays
2026-06-22
This article guides biomedical researchers through common laboratory challenges in apoptosis and cytotoxicity assays, focusing on the scientific and workflow benefits of ABT-737 (SKU A8193). Scenario-driven Q&A blocks offer evidence-based solutions, highlighting APExBIO’s product quality and data-backed performance in cancer research, including lymphoma, multiple myeloma, SCLC, and AML applications.
-
Calpeptin in Fibrosis & Cell Death: Mechanistic Insights for
2026-06-22
Explore the mechanistic depth of Calpeptin as a calpain inhibitor in fibrosis and apoptosis research. This article uniquely bridges molecular cell death pathways and practical assay design, empowering advanced fibrosis and inflammation studies.
-
Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei
2026-06-21
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) delivers robust serine/threonine phosphatase inhibition, empowering researchers to preserve delicate phosphorylation states during protein extraction and analysis. Its broad-spectrum efficacy and compatibility with advanced workflows set a new standard for reproducible phosphoprotein studies.
-
Phosbind Acrylamide: Advancing Phosphorylation Analysis Work
2026-06-20
Phosbind Acrylamide enables rapid, antibody-free differentiation of phosphorylated proteins by SDS-PAGE, streamlining signal transduction research. Its high specificity and compatibility with physiological pH empower researchers to dissect phosphorylation events in stress responses and kinase assays with unmatched clarity.
-
Exendin-4 (Exenatide): Applied Workflows in Diabetes Researc
2026-06-19
Explore how Exendin-4 (Exenatide) empowers researchers to model insulin sensitivity, beta cell function, and hepatic steatosis reversal in translational type 2 diabetes studies. This guide distills latest recombinant production advances, actionable protocols, troubleshooting tips, and real-world workflow optimizations.
-
LDH Cytotoxicity Assay Kit: Next-Gen Biocompatibility Insigh
2026-06-19
Discover how the LDH Cytotoxicity Assay Kit advances cell cytotoxicity measurement, enabling deeper biocompatibility analysis for nanomaterials and disease models. This article reveals practical, evidence-based strategies for unlocking high-sensitivity, non-radioactive workflows.
-
Dextrose (D-glucose) in Advanced Glucose Metabolism Research
2026-06-18
Dextrose (D-glucose) from APExBIO empowers high-precision modeling of metabolic reprogramming in hypoxia and immunometabolic studies. With robust solubility and validated purity, it is the go-to substrate for reproducible cell-based and translational workflows.
-
Porous Graphene Films Enable High-Resolution MSI of Ethanol-
2026-06-18
This study presents laser-induced graphene (LIG) as a novel substrate for laser desorption/ionization mass spectrometry imaging (LDI-MSI). By overcoming matrix-related limitations, the method achieves 3-μm spatial resolution, revealing dynamic spatial and temporal metabolic asymmetry in mouse brain lipids after ethanol exposure.
-
TRPV1+ Peripheral Nerve Stimulation Suppresses Inflammation
2026-06-17
Song et al. (2025) identify a neural circuit whereby targeted stimulation of TRPV1+ peripheral somatosensory nerves robustly suppresses systemic inflammation via a somato-autonomic reflex. This work reveals mechanistic details relevant for inflammation research and highlights TRPV1 agonists, such as Nonivamide, as valuable experimental tools for neuroimmune modulation.
-
Sabutoclax: Advanced Insights for Pan-Bcl-2 Inhibitor Assay
2026-06-17
Explore how Sabutoclax, a potent pan-Bcl-2 inhibitor, enables more precise and informative apoptosis induction assays in cancer research. This article uniquely bridges nuanced in vitro evaluation with practical protocol optimization.
-
Green Spectrophotometric Quantification of Alfuzosin HCl in
2026-06-16
Alqahtani et al. (2024) introduce the first validated green spectrophotometric methods for simultaneous quantification of Alfuzosin HCl and tadalafil in binary formulations, addressing spectral overlap challenges without chromatographic separation. These accessible techniques streamline quality control and formulation analysis in benign prostatic hyperplasia (BPH) research.
-
IWP-2: Precision Wnt Production Inhibitor for Cancer Researc
2026-06-16
IWP-2 empowers targeted disruption of Wnt signaling at the Porcupine (PORCN) level, enabling reproducible manipulation of cell fate and tumor biology. This guide details optimized workflows, real-world troubleshooting, and protocol enhancements for maximizing IWP-2's impact in apoptosis, migration, and pathway analysis assays.
-
HotStart 2X Green qPCR Master Mix: Precision in Gene Quantif
2026-06-15
The HotStart™ 2X Green qPCR Master Mix streamlines gene expression quantification with exceptional specificity, leveraging antibody-mediated hot-start Taq polymerase inhibition. Its optimized formulation elevates sensitivity and reproducibility, making it essential for demanding applications such as RNA-seq validation and real-time PCR gene expression analysis.